Results 151 to 160 of about 6,989 (168)

PARG inhibitory compounds

2019
MCGONAGLE ALISON E, JORDAN ALLAN M, WASZKOWYCZ BOHDAN, HUTTON COLIN P, WADDELL IAN D, HITCHIN JAMES R, SMITH KATE M, HAMILTON NIALL M   +7 more
openaire   +5 more sources

Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation

Cancer Gene Therapy, 2012
Y-L Wang
exaly  

PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.

FASEB Journal, 2005
Salvatore Cuzzocrea, Rosanna Di Paola, Tiziana GENOVESE   +2 more
exaly  

PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer

Proceedings of the National Academy of Sciences of the United States of America
Alan D'Andrea, Geoffrey I Shapiro
exaly  

Prospects for PARG inhibitors in cancer therapy Open Access

Journal of Molecular Cell Biology
Ji Jing, Zu Ye, Yangchan Hu
exaly  

PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy

Journal of Hepatology
Hui Li, Ye Qinghai, Peiyi Xie
exaly  

INHIBITORS OF PARG

WIDDOWSON KATHERINE, CHANG PAUL, QIAN XIJUN, WANG YANLI, TAN ENWANG   +4 more
openaire   +3 more sources

PARG INHIBITORS AND METHOD OF USE THEREOF

2020
YU XIAOCHUN, CHEN SHIH-HSUN, HORNE DAVID, XIE JUN   +3 more
openaire   +2 more sources

The Promises and Pitfalls of Small-Molecule Inhibition of Poly(ADP-Ribose) Glycohydrolase (PARG)

Paul J. Hergenrother
exaly  

PARG, a GTPase activating protein which interacts with PTPL1

1998
SARAS JAN, FRANZEN PETRA, ASPENSTROM PONTUS, HELLMAN ULF, GONEZ LEONEL JORGE, HELDIN CARL-HENRIK   +5 more
openaire   +2 more sources